Challenging Cases in Cervical Cancer: Parametrial Boosting. Beth Erickson, MD, FACR, FASTRO Medical College Wisconsin

Similar documents

Interstitial Brachytherapy. Low dose rate brachytherapy. Brachytherapy alone cures some cervical cancer. Learning Objectives

MRI Guided GYN Brachytherapy: Clinical Considerations

EMBRACE- Studien Analysen und Perspektiven

Definitions. Brachytherapy in treatment of cancer. Implantation Techniques and Methods of Dose Specifications. Importance of Brachytherapy in GYN

Intracavitary + Interstitial Techniques Rationale

Outline - MRI - CT - US. - Combinations of imaging modalities for treatment planning

The New ICRU/GEC ESTRO Report in Clinical Practice. Disclosures

Basics of Cervix Cancer Brachytherapy

3D ANATOMY-BASED PLANNING OPTIMIZATION FOR HDR BRACHYTHERAPY OF CERVIX CANCER

INTRODUCTION PATIENT. J. Radiat. Res., 52, (2011)

Linking DVH-parameters to clinical outcome. Richard Pötter, Medical University of Vienna, General Hospital of Vienna, Austria

Gynecologic Vaginal Brachytherapy (Mostly Post-Op Endometrial)

Advances in Gynecologic Brachytherapy

Basic Concepts in Image Based Brachytherapy (GEC-ESTRO Target Concept & Contouring)

ICRT รศ.พญ.เยาวล กษณ ชาญศ ลป

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX

Dose-Volume Histogram Analysis in Point A-based Dose Prescription of High-dose-rate Brachytherapy for Cervical Carcinoma

An Update on Radiation Therapy for Prostate Cancer

Patterns of Care in Patients with Cervical Cancer:

Image based Brachytherapy- HDR applications in Gynecological Tumors

IMRT - the physician s eye-view. Cinzia Iotti Department of Radiation Oncology S.Maria Nuova Hospital Reggio Emilia

ARROCase: Locally Advanced Endometrial Cancer

Gyn Pre-planning: Intracavitary Insertion

The Evolution of RT Techniques for Gynaecological Cancers in a developing country context

Dosimetric Analysis of 3DCRT or IMRT with Vaginal-cuff Brachytherapy (VCB) for Gynaecological Cancer

Basic Fundamentals & Tricks of the Trade for Intracavitary Radiotherapy for Cervix Cancer. Paula A. Berner, B.S., CMD, FAAMD

Current Status of Image Guided Brachytherapy for Cervical Cancer In Japan

Original Date: June 2013 Page 1 of 7 Radiation Oncology Last Review Date: September Implementation Date: December 2014 Clinical Operations

GYNECOLOGIC CANCER and RADIATION THERAPY. Jon Anders M.D. Radiation Oncology

CT Guided Contouring: Challenges and Pitfalls

Image guided brachytherapy in cervical cancer Clinical Aspects

CT Guided Contouring: Challenges and Pitfalls

Enterprise Interest None

HDR Brachytherapy I: Overview of Clinical Application and QA. Disclosures. Learning Objectives 7/23/2014. Consultant, Varian Medical Systems

Locally advanced disease & challenges in management

Johannes C. Athanasios Dimopoulos

The Role of Radiation in the Management of Gynecologic Cancers. Scott Glaser, MD

presenting Brachytherapy with focus on Gynecological Cancers

20 Prostate Cancer Dan Ash

Recent Advances and current status of radiotherapy for cervix cancer

It s All About Margins. Maaike Milder, Ph.D. Accuray Symposium April 21 st 2018

Brachytherapy in Africa

A Comparison of IMRT and VMAT Technique for the Treatment of Rectal Cancer

Course Directors: Teaching Staff: Guest Lecturers: Local Organiser: ESTRO coordinator: Melissa Vanderijst, project manager (BE)

New research in prostate brachytherapy

High dose-rate tandem and ovoid brachytherapy in cervical cancer: dosimetric predictors of adverse events

Modern Interstitial GYN Brachytherapy. Conflicts: 8/3/2016. Modern Interstitial GYN Brachytherapy. 1. Use of MR

Course Directors: Teaching Staff: Guest Lecturers: Local Organiser: ESTRO coordinator: Melissa Vanderijst, project manager (BE)

Beam Direction RAO LAO. Pt supine. LL Treatment couch LPO RPO. WHA Consulting. Wilson Apollo

Role of IMRT in the Treatment of Gynecologic Malignancies. John C. Roeske, PhD Associate Professor The University of Chicago

Image guided adaptive brachytherapy in patients with cervical cancer

Use of imaging systems for patient modeling - PET and SPECT

Index. T1 and T2-weighted images, 189

Course Directors : Teaching Staff : Guest Lecturer: Local Organiser: ESTRO coordinators: Melissa Vanderijst and Marta Jayes, project managers (BEL)

GYN GEC-ESTRO/ICRU 89 Target Concept. Richard Pötter Medical University Vienna

Cervical Cancer 3/25/2019. Abnormal vaginal bleeding

University Cooperation Platform

Q&A. Overview. Collecting Cancer Data: Prostate. Collecting Cancer Data: Prostate 5/5/2011. NAACCR Webinar Series 1

Dosimetric comparison of interstitial brachytherapy with multi-channel vaginal cylinder plans in patients with vaginal tumors

NIH Public Access Author Manuscript Int J Radiat Oncol Biol Phys. Author manuscript; available in PMC 2015 July 01.

High resolution (3 Tesla) MRI-guided conformal brachytherapy for cervical cancer: consequences of different high-risk CTV sizes

Stereotactic MR-guided adaptive radiation therapy (SMART) for locally advanced pancreatic tumors

Nordic Society for Gynecological Oncology Advisory Board of Radiotherapy

Comparison of rectal and bladder ICRU point doses to the GEC ESTRO volumetric doses in Cervix cancer

Original Article ABSTRACT INTRODUCTION

Collection of Recorded Radiotherapy Seminars

NEWER RADIATION (3 D -CRT, IMRT, IGRT) TECHNIQUES FOR CERVICAL CANCERS (COMMON PELVIC TUMORS)

GOROC POSITION PAPER ON IGBT FOR CERVICAL CANCER FACULTY OF RADIATION ONCOLOGY THE ROYAL AUSTRALIAN AND NEW ZEALAND COLLEGE OF RADIOLOGISTS

Cervical Cancer Treatment

Regulatory Guidelines and Computational Methods for Safe Release of Radioactive Patients II. Brachytherapy

HHS Public Access Author manuscript Gynecol Oncol. Author manuscript; available in PMC 2018 May 01.

Who Should Know Radiation Oncology Coding?

Gynecologic Cancer InterGroup Cervix Cancer Research Network. Management of Cervical Cancer in Resource Limited Settings.

Review of brachytherapy in

MR-Guided Brachytherapy

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

High-Dose-Rate Orthogonal Intracavitary Brachytherapy with 9 Gy/Fraction in Locally Advanced Cervical Cancer: Is it Feasible??

Clinical Study Stereotactic Body Radiotherapy as an Alternative to Brachytherapy in Gynecologic Cancer

Developments in Directional Brachytherapy William Y. Song, PhD, DABR

New Technologies for the Radiotherapy of Prostate Cancer

Staging and Treatment Update for Gynecologic Malignancies

2015 Radiology Coding Survival Guide

Version A European study on MRI-guided brachytherapy in locally advanced cervical cancer EMBRACE (ENDORSED BY GEC ESTRO)

A Study on Dosimetry of Gynaecological Cancer and Quality Assurance of HDR Brachytherapy in BPKMCH, Nepal

Preliminary reports. Primoz Petric, MD, MSc, Robert Hudej, PhD, Maja Music, MD. Abstract. Introduction

REVISITING ICRU VOLUME DEFINITIONS. Eduardo Rosenblatt Vienna, Austria

Brachytherapy Planning and Quality Assurance w Classical implant systems and modern computerized dosimetry w Most common clinical applications w

Limitations. General Clinical Applications of Brachytherapy Physics. Learning Objectives. Conflicts of Interest. University of Wisconsin - Madison

Brachytherapy Planning and Quality Assurance

Clinical implementation of multisequence MRIbased adaptive intracavitary brachytherapy for cervix cancer

Case Scenario 1. History

Does conformal therapy improve dose distribution in comparison to old techniques in teleradiotherapy of cervical cancer patients?

Radiotherapy physics & Equipments

Modern Dose Fractionation and Treatment Techniques for Definitive Prostate RT

Early clinical outcomes of 3D-conformal radiotherapy using. accelerated hyperfractionation without intracavitary brachytherapy

Treatment Planning for Breast Cancer: Contouring Targets. Julia White MD Professor

La Pianificazione e I Volumi di Trattamento

Silvia Pella, PhD, DABR Brian Doozan, MS South Florida Radiation Oncology Florida Atlantic University Advanced Radiation Physics Boca Raton, Florida

Comparison of high-dose-rate intracavitary brachytherapy dosimetry with and without anesthesia in patients with cervical carcinoma

Transcription:

Challenging Cases in Cervical Cancer: Parametrial Boosting Beth Erickson, MD, FACR, FASTRO Medical College Wisconsin

Disclosure Chart Rounds participant No COI

Learning Objectives Discuss the challenges of boosting the parametria Discuss external beam strategies for boosting the parametria Discuss brachytherapy strategies for boosting the parametria

42 y/o pt with a 10 mo. history of increasing pelvic pain and difficult BMs with weight loss. Endoscopy and pelvic exam negative initially. Eventual discovery of a 6 cm posterior lip cervical cancer involving the right uterosacral ligament and compressing the rectum Biopsy + for poorly diff adenocarcinoma. Stage IIIB

Pelvic external beam 45 Gy, 4 field 3D conformal and weekly Cis P Transperineal interstitial implant 22 needles and tandem; 5 HDR fx of 450 cgy periphery/540 cgy core(~75gy/83 Gy LDR equivalent) Parametrial boosting 3.6 Gy split pelvis and 10.8 Gy to right pelvic sidewall Repeat MR after 45 Gy

Pt had resolution of presenting symptoms with negative 3 mo.pet Rectal bleeding 9 months later Endoscopyangiodysplasias of the rectum argon plasma coagulation(apc) X 3 and carafate enemas Rare bleeding at 24 mo. Patient NED at 24 mo.

Parametrial/Paracervical Tissue Fat and loose connective tissue and smooth muscle around the uterus and cervix Contains blood vessels and lymph nodes 30% of pts with localized disease will have pathologic involvement Disease may extend from the primary or be discontinuous and throughout the parametria Netter F. Atlas of Human Anatomy 4 th Ed Good et al Brachytherapy 11(2012):77 79.

Lim et al IJROBP, 2010

The Traditional Approach External Beam Doses for Cervical Cancer Whole pelvis 4500 cgy Split pelvis (midline block) 5040 cgy Parametrial boosts 5400 5940 cgy

The clinical challenge: How do you reach the parametria? 3D conformal boost with MLB? IMRT boost? Interstitial brachytherapy boost? Good et al Brachytherapy 11(2012):77 79.

3D Conformal Midline Blocks Intended to avoid regions of excessive dose adjacent to the implant, but deliver adequate dose to tumorbearing regions outside of implant

3D Conformal Midline Blocks Parametrial boosts traditionally done with AP PA fields with a MLB 1) standardized rectangular or 2) customized to an ICBT isodose line. Used by major centers for years No additional investment in software or equipment Time honored

It is current standard practice not to consider the radiation dose to the bladder and rectum from the parametrial boosts because these organs are blocked by the midline shield Ting, Radiology 209:825 830, 1998

Problems with Midline Blocks: Blocking too Little Portions of the bladder and rectosigmoid are not under the midline block and will get both the brachytherapy doses and WP and PM doses. 4 cm midline block Fenkell et al IJROBP (2011)79:1572 1579

Problems with Midline blocks Blocking too Little Huang Gyn Onc (2000)79:406 410 The packed applicator may move cephalad towards the rectosigmoid during the implant The upper rectum and rectosigmoid may extend above the midline block after the implant The upper rectum and rectosigmoid are not always midline Rectosigmoid Complications NPMB= 40 45 Gy; LPMB=50 54 Gy; HPMB= > 54 Gy

Problems with Midline Blocks: Blocking too Little Ext beam WP D2cc Bladder D2cc Rectum D2cc Sigmoid 45.0 Gy 83.8 57.5 71.4 50.4 Gy 85.9 59.6 73.5 55.8 Gy 88.0 61.7 75.6 59.4 Gy 89.4 63.1 77.0

The Challenge of Uterosacral ligament Involvement Safer to avoid early in treatment if uterosacral ligament involvement Midline Blocks Chao; IJROBP 40:1998 May want to consider oblique boosts with uterosacral ligament involvement

Outcomes with Parametrial Boosts No consensus as to indications, optimal technique, or dose of PMB Typically for bulky IIB and IIIB patients PMB range: 5 20 Gy after 40 50 Gy WP Total dose 60 62 Gy (range 50 70 Gy) Perez; Cancer 51:1983 (Viswanathan IJROBP 2011) Perez IJROBP 41(2):307 317,1998) Some correlation with local control and PMB dose( < 50 Gy) but higher doses only associated with increased complications

Technical Challenges Integrating Brachytherapy and External Beam Most external beam and brachytherapy treatment planning systems cannot integrate to add external beam and brachytherapy doses together Lack of a True cumulative dose to Tumor and OAR

IMRT Parametrial Boosting Concurrent SIB offers accelerated fractionation to bulky disease and standard fractionation to microscopic disease Does not require isodose matching or adding two IMRT plans How do you separate the parametrial disease from the central cervical disease? Easier to do for nodes! Sequential IMRT boost takes disease regression into account with decreased boost volume Not always a visible parametrial GTV after external beam but there may still be palpable retraction towards a sidewall Good et al Brachytherapy 11(2012):77 79.

Integration of External Beam and Brachytherapy To improve outcomes in patients with cervical cancer, the external beam doses and techniques must be scrutinized and controlled just as carefully as the brachytherapy doses and techniques

Parametrial Dose from Brachytherapy Dose specification: HR CTV D90 >85 Gy (80 90 Gy); D90> 87 Gy bulky tumors Dose escalation for large tumors with interstitial needles added to the ring Dose volume constraints for OAR: (D2cc) Rectum < 70 75 Gy Sigmoid < 70 75 Gy Bladder < 90 Gy

Parametrial Boost with Brachytherapy Intracavitary/interstitial Applicators Intracavitary/Interstitial Tandem and Ring, Tandem and ovoids 60% of tumors can be covered with IC and the remaining require IC interstitial Only 5% require templatebased interstitial 10 20% of total dwell time comes from the needles and the remainder from IC T/R Tanderup et al Rad Onc 94:173 180,2010

Image Guided Adaptive Parametrial Boost Supplement brachytherapy boost with a high precision, high gradient stereotactic hypofractionated IMRT boost to the under dosed part of the HR CTV. IMRT boost is planned and delivered with the brachytherapy applicator in place Requires integration of external beam and brachytherapy TP systems Assenholt et al Acta Oncol 2008;47:1337 1343 Tanderup et al Radiother Oncol 2010; 96: S427 S428.

Image Guided Adaptive Parametrial Boost Assenholt et al Acta oncologica 2008:47:1337 1343

Interstitial techniques Template based approaches are indicated for bulky disease after external beam Can selectively implant one or both parametria Can implant medial and some of the lateral parametria May not cover uterosacral ligaments well or lateral parametrial disease

How do you do your parametrial boosts? 1. Midline block/3d conformal 2. IMRT 3. SBRT 4. Tandem and ring/ovoids with needles 5. Transperineal interstitial implant

Questions?